Skip to main content

Advertisement

Table 1 Clinical and demographic characteristics of the patients included in the study

From: Point-of-care lung ultrasound for diagnosis of Pneumocystis jirovecii pneumonia: notes from the field

  Total n = 24 (100%) PJP+ n = 14 (58.33%) PJP− n = 10 (41.66%) p-value
Sex males/females (% males) 18/6 (75.00%) 13/1 (92.85%) 5/5 (50.00%) 0.0501
Median age in years (IQR) 44 (36–53) 43 (35–54) 44 (41–51) 0.8602
Ethnic origin (n)
 Caucasian 18 11 7  
 African 3 1 2  
 Latin-American 3 2 1  
Median CD4+ T cells/μl on admission (IQR) 56.5 (18–172.25) 39.5 (16–73.5) 137.5 (59.75–325) 0.0608
Median viral load in copies/ml on admission (IQR) 345,000 (91,427–607,400) 262,450 (61,291–587,150) 391,200 (195,400–790,400) 0.8291
PJP as first AIDS-defining condition n.a. 13/14 (92.85%) n.a.  
Final diagnosis PJP See notea  
  1. PJP, Pneumocystis jirovecii pneumonia; IQR, inter quartile range; n.a., not applicable
  2. aFinal diagnoses of PJP-patients: bacterial pneumonia (n = 3), TB (n = 3), disseminated Cytomegalovirus infection (n = 1) and Mycobacterium avium complex infection (n = 1) with lung involvement, non-Hodgkin’s T cell lymphoma (n = 1) and adenocarcinoma (n = 1) of the lung